Hong Kong, Beijing and Shanghai – August 12, 2024 – China Business Law Journal has honored Cooley as part of its China Business Law Awards 2024, which recognize the best Chinese and international law firms in various practice area categories for the Chinese market.
Cooley was newly listed among the top capital markets practices in the Hong Kong & Overseas category – the firm’s first such honor since 2019, when Cooley built upon its global success and established its Asia capital markets practice in Hong Kong, a leading center for finance and innovation.
For the sixth consecutive year, Cooley was noted among the top international law firms in CBLJ’s Private Equity and Venture Capital and Healthcare, Pharma and Life Sciences categories. And, for the fourth year in a row, the firm was listed in the Asset Management category.
The firm’s private equity practice was noted for representing SJSemi, a semiconductor foundry, in its $340 million Series C+ financing, which brought the company to a valuation close to $2 billion. In the life sciences space, the firm was noted for representing Lilly Asia Ventures in its participation in the $155 million Series B financing of ArriVent Biopharma.
Cooley’s Beijing, Hong Kong and Shanghai offices represent a growing number of China’s most innovative and dynamic tech and life sciences companies, advising them from formation through financings and exits. The team’s in-depth subject matter knowledge and transactional prowess enable the firm to handle a raft of capital markets, M&A, corporate, and finance work for international and China-based high-tech and life sciences entities engaged in inbound and outbound endeavors.
Clients partner with Cooley on transformative deals, complex IP and regulatory matters, and high-stakes litigation, where innovation meets the law.
Cooley has 1,300+ lawyers across 19 offices in the United States, Asia and Europe, and a total workforce of more than 3,000.
This content is provided for general informational purposes only, and your access or use of the content does not create an attorney-client relationship between you or your organization and Cooley LLP, Cooley (UK) LLP, or any other affiliated practice or entity (collectively referred to as “Cooley”). By accessing this content, you agree that the information provided does not constitute legal or other professional advice. This content is not a substitute for obtaining legal advice from a qualified attorney licensed in your jurisdiction and you should not act or refrain from acting based on this content. This content may be changed without notice. It is not guaranteed to be complete, correct or up to date, and it may not reflect the most current legal developments. Prior results do not guarantee a similar outcome. Do not send any confidential information to Cooley, as we do not have any duty to keep any information you provide to us confidential. This content may be considered Attorney Advertising and is subject to our legal notices.